T4 DNA ligase reduces chromosome damage and enhances cell survival in CHO cells treated with bleomycin

Cytogenetics and Cell Genetics

Volumn 78, Issue 3-4, 1997, Pages 197-201

  Ortiz, T ^a   Flores, M J ^a   Pinero J ^a   Cortes F ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE;

ANIMAL CELL; ARTICLE; BACTERIOPHAGE T4; CELL SURVIVAL; CHO CELL; CHROMOSOME DAMAGE; CLONOGENIC ASSAY; CYTOGENETICS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BLEOMYCIN; CELL SURVIVAL; CHO CELLS; CRICETINAE; DNA DAMAGE; DNA LIGASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPORATION;

ANIMALIA; T4 PHAGE;

EID: 0031471639     PISSN: 03010171     EISSN: 1424859X     Source Type: Journal    
DOI: 10.1159/000134656     Document Type: Article

References (35)

1. Belchradek Jr. J, Orlowski S, Ramírez LH, Pron G, Pod-devin B, Mir LM: Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin, Biochim biophys Acta 1190:155-163 (1994).
2. Bienkorvska ZM, Dawson KB, Peacock JH: Action of actinomycins, bleomycin and x-rays on HeLa cells, Br J Radiol 46:619-622 (1973).
3. Bryant PE, Johnston PJ: Rcstriction-endonuclcasc-in-duccd DNA double-strand breaks and chromosomal aberrations in mammalian cells, Mutat Res 299:289-296 (1993).
4. Caldecott KW, McKeown CK, Tucker JD, Ljunquist S, Thompson LH: An interaction between the mammalian DNA repair protein XRCCI and DNA ligase III, Mol cell Biol 14:68-76 (1994).
5. Carter SK, Crookc ST, Umezawa H (eds): Bleomycin: Current Status and New Developments (Academic Press, Tokyo 1978).
6. Carter SK, Ichikawa T, Mathe A, Umezawa H (eds): Fundamental and Clinical Studies of Bleomycin, Gann Monograph on Cancer Research, No 19 (Tokyo University Press, Tokyo 1976).
7. Cortés F, Ortiz T: Induction of chromosomal aberrations in the CHO mutant EM9 and its parental line AA8 by EcoRI restriction endonuclease: electroporation experiments, Mutat Res 246:221-226 (1991).
8. Cortés F, Panneerselvam N, Mateos S, Ortiz T: Poly-D-Iysine enhances the genotoxicity of bleomycin in cultured CHO cells, Carcinogenesis 14:2543-2546 (1993).
9. Dar ME, Jorgensen TJ: Deletions at short direct repeats and base substitutions are characteristic mutations for bleomycin-induced double- and single-strand breaks, respectively, in a human shuttle vector system, Nucl Acids Res 23:3224-3230 (1995).
10. Dresp J, Schmid E, Bauchingcr M: The cytogenetic effect of bleomycin on human peripheral lymphocytes in vitro and in vivo, Mutat Res 56:341-353 (1978).
11. Durante M, Grossi GF, Napolitano N, Gialaneila G: Repair of potentially lethal damage by introduction of T4 DNA ligase in eukaryotic cells, Int J radial Biol 59:963-971 (1991).
12. Errami A, Smider V, Rathmell WK, He DM, Hendrickson EA, Zdzienieka MZ, Chu G: Ku 86 defines the genetic defect and restores x-ray sensitive and V (D)J recombination to complementation group 5 hamster cell mutants, Mol cell Biol 16:1519-1526 (1996).
13. Friedbcrg EC, Walker GC, Siedc W: DNA Repair and Mutagenesis (ASM Press, Washington DC 1995).
14. Gu X-Y, Bennet RAO, Povirk LF: End-joining of free radical-mediated DNA double-strand breaks in vitro is blocked by the kinase inhibitor wonmannin at a step preceding removal of damaged 3' termini, J biol Chem 271:19660-19663 (1996).
15. Hiakis G: Radiation-induced potentially lethal damage: DNA lesions susceptible to fixation, Int J radial Biol 53:541-584 (1988).
16. Johnston PJ, Bryant PE: Chromosome damage induced by nanomolar concentrations of bleomycin in po-rated mammalian cells, Biochem Pharm 45:569-572 (1993).
17. Kauffman WK, Paules RS: DNA damage and cell cycle checkpoints, FASEB J 10:238-247 (1996).
18. Kligerman AD, Bryant MF, Doerr CL, Halpcrin EC, Kwanyuen P, Sontag MR, Erexson GL: Inlerspe-cies cytogenetic comparisons: studies with x-radia-tion and bleomycin sulphate, Environ molec Mutat 19:235-243 (1992).
19. Kuo MT: Preferential damage of active chromatin by bleomycin, Cancer Res 41:2439-2443 (1981).
20. Lehman IR: DNA ligase: structure mechanism and function, Science 186:790-797 (1974).
21. Morgan WF, Agcr D, Chung HW, Ortiz T, Phillips J W, Winegar RA: The cytogenetic effects of restriction endonucleases following their introduction into cells by electroporation, in Mutation and the Environment, Part B, pp 355-361 (Wiley-Liss, New York 1990).
22. Ortiz T, Daza P, Pinero J, Cortés F: T4 DNA ligase modulates chromosome damage induced by restriction endonucleases through an error-free process, Mutagenesis 10:399-402 (1995).
23. Östling O, Johanson KJ: Bleomycin, in contrast to gamma irradiation, induces extreme variation of DNA strand breakage from ceil to cell, Int J Radial Biol 52:683-691 (1987).
24. Ozawa S, Suzuki H, Nishumura T, Tanaka N: Cellular uptake and efflux of peplomycin in sensitive and bleomycin resistant subline of mouse lymphoma L5178Y cells, J Antibiot 93:395-397 (1988).
25. Perry P, Wolf S: New Giemsa method for the differential staining of sister chromatids, Nature 251:156-158 (1974).
26. Povirk LF, Austin MJF: Genotoxicity of bleomycin, Mutat Res 257:127-143 (1991).
27. Ray E, Yaneva J, Ivanchenko M, van Holde K, Zlata-nova J: Linker histones inhibit T4 and Escherichia coli DNA ligases, Biochem biophys Res Commun 222:512-518 (1996).
28. Roth DB, Lindahl T, Geliert M: How to make ends meet, Curr Biol 5:496-499 (1995).
29. Roy SM, Horwitz SB: Characterization of the association of radiolabellcd bleomycin A2 with HeLa cells, Cancer Res 44:1541-1546 (1984).
30. Rusche JR, Königsberg W, Howards-Flandcrs P: Isolation of altered recA polypeptides and interaction with ATP and DNA, J biol Chem 260:949-955 (1985).
31. Sargentini NJ, Smith KC: Quantitation of the involvement of the recA, recB, recC, recE, recJ, recN, IcxA, rail A radB, uvrD and umuC genes in the repair of X-ray-induced DNA double-strands breaks in Escherichia coli, Radiat Res 107:58-72 (1986).
32. Sidik K, Smcrdon MJ: Bleomycin-induced DNA damage and repair in human cells permeabilized with lysophosphatidylcholine, Cancer Res 50:1613-1619 (1990).
33. Söderhäll S, Lindahl T: DNA ligases of eukaryotes, FEBSLett 67:1-8 (1976).
34. Tounekti O, Belehradek J, Mir LM: Bleomycin, an apoptosis-mimetic drug, Bull Cancer 81:1043-1049 (1994).
35. Tounekti O, Pron G, Belehradek J, Mir LM: Bleomycin, an apoptosis-mimctie drug that induces two types of cell death depending on the number of molecules internalized, Cancer Res 53:5462-5469 (1993).